"FAIR BALANCE" IN COMPARATIVE DRUG ADS REQUIRES MENTIONING ADVANTAGES OF COMPETITORS's DRUG AS WELL AS PROMOTED PRODUCT, FDA's BANKS TELLS RAPS MEETING